Member Info for Seaking1

Many thanks for the info. Good to have another type of vaccine . If it goes ok in trials it will be interesting to see how the different types of vaccines perform over time. The one thing that has come out of this pandemic is that governments have had to put money into science which they never have before thereby bringing on the science in viruses in leaps.

Cheers , that’s better. I know a lot about GSK having followed and been invested for about 5 years now and have a substantial amount invested. (For me). :-).

Neither can I, :-).

Could well be a drop on the news about delays in the vaccine and having to ramp up production in Belgium.

I’m full up in GSK. So my next buy is going into either. Oxford biomedica sub 900 or S4capital sub 530 whichever comes first I hope.

Both GSK and AstraZeneca are down at the moment from what they were awhile ago. But most big
Funds are saying that the uk looks cheap so maybe when the inflows of cash come in they will both rise with the footsie.

GSK are only in JV to help Sanfoi with logistics an Adjvant platform . ? Logistics, an adjuvant platform. what do you mean puzzled.

Yes I still think it’s a good share but like you think it’s also worth taking a profit and hoping for a drop to get back in . I have a small amount as a core holding . I’m sure he’s bearing a massive grudge toward WPP . Maybe that is what’s driving him to get back.

Good luck on your next buy. I will take your place when the sp drops to 900<

Short answer to that is nobody knows except the directors of Pfizer and GSK. I bought av 1650 but although the sp is down I am ok with it as I expect the sp to stay in a range between 1350 - 14 50 until the split and expect to see upward movement before the split date. The one thing I have mentioned in past posts is that in my opinion the new HIV medication has been overlooked and will prove to be a good source of future profits/growth.

Still has, I’m afraid you will have to wait longer before the money starts flowing into the Oxford coffers

Dawson was working for Cephalon ( pharma company) before joining Oxford.
Diggle is the one to keep your eye on.

I ain’t that rich:-)

Peter Kim sold almost 1.7 million shares on the 12.01.2021. For 500p

Looks like the sp is being manipulated trying to falsely drive the sp up .

I was going to buy at 900 but I think I will wait as the sp may still drop . Nothing lost if it goes up.
Also keeping my eye on S4 cap. But need it to drop a good bit.

That when the next results come in that there will be the £15 million pounds upfront payment from AstraZeneca for the covid vaccine and the ongoing £35 million that they will earn from the production of it although that may not show up in the results

Scottish mortgage charges 0.37 were as BGCG charges 0.92 both are to run the fund and are separate charges from what your broker charges you.

The amount you pay is in my view ok. On another note you still get charged by the fund manager which is taken out of the fund.

Sorry wrong fund although I have this one . Meant to say bg China growth fund.